1. Payami H, Zareparsi S. Genetic epidemiology of Parkinson’s disease. J Geriatr Psychiatry Neurol 1998; 11(2): 98-106.
2. Riess O, Kuhn W, Kruger R. Genetic influence on the development of Parkinson’s disease. J Neurol 2000; 24(2): 69-74.
3. Gupta AM, Felten DL, Ghetti B. Selective loss of monoaminergic neurons in the weaver mutant mice: an immunocytochemical study. Brain Res 1987; 102: 379-382.
4. Gaspar P, Ben Jelloun N, Febvret A. Sparing of the dopaminergic neurons containing calbindin-D28K and of the dopaminergic mesocortical projections in weaver mutant mice. Neuroscience 1994; 61(2): 293-305.
5. Tsaur ML, Menzel S, Lai FR, Espinosa RIII, Concannon P, Spielman RS, Hanis CL, Cox NJ, Le Beau MM, German MS, Jan LY, Bell GI, Stoffel M. Isolation of a cDNA clone encoding a KATP channel-like protein expressed in insulin-secreting cells, localization of the human gene to chromosome band 21q22.1, and linkage studies with NIDDM. Diabetes 1995; 44(5): 592-596.
6. Goldowitz P, Smeyne R.J. Tune into the weaver channel. Nat Genet 1995; 11(2): 107-109.
7. Bandmann O, Davis MV, Marsden CD, Wood N.W. The human homologue of the weaver mouse gene in familial and sporadic Parkinson’s disease. J Neurosci 1996; 4(72): 877-879.
8. Patil N, Cox DR, Bhat D, Faham M, Myers RM, Peterson AS. A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nat Genet 1995; 11(2): 126-129.
9. Yamada M, Inanobe A, Kurachi Y. G protein regulation of potassium ion channel. Pharmacol Rev 1998; 50(4): 723-757.
10. Deininger PL, Batzer MA. Alu-repeats and human disease. Mol Genet Metab 1999; 67(3): 183-193.
11. Mathew CC. The isolation of high molecular weight eukaryotic DNA. In: Walker JM, Ed. Methods in Molecular Biology. New York: Human Press. 1984; Vol. 11, 31‑34.
12. Yates F. Tests of significance for 2x2 contingency tables. J Roy Stat Soc 1984; A147: 426-463.
13. Daly LE, Bourke GJ. Interpretation and Uses of Medical Statistics. Oxford: Blackwell Scientific Publications, 2000.
14. Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall, 1992.
15. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. J Neurol 1967; 17(5): 427-442.
16. Guatteo E, Fusco FR, Giacomini P, Bernardi G, Mercuri NB. The weaver mutation reverses the function of dopamine and GABA in mouse dopaminergic neurons. J Neurosci 2000; 20(16): 6013-6020.
17. Guatteo E, Bengtson CP, Bernard G. Voltage-gated calcium channels mediate intracellular calcium increase in weaver dopaminergic neurons during stimulation of D2 and GABA B receptors. J Neurosci 2004; 92(6): 3368-3374.
18. Norris J, Fan D, Aleman C, Marks JR, Futreal PA, Wiseman RW, Iglehart JD, Deininger PL, McDonnell DP. Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J Biol Chem 1995; 270(39): 22777-22782.
19. Batzer M, Deininger PL. Alu-repeats and human genomic diversity. Nat Rev 2002; 3(5): 370-379.
